FDA has approved use of patient’s personal glucometer for POCT inpatient.
4 followers
0 Likes
How are your facilities responding to the new FDA ruling; specifically to address the needs of diabetic patients who are COVID 19 positive and limit exposure for nursing staff. I look forward to your input.
Thank you,
Melisand
Sent via Groupsite Mobile.
https://www.fda.gov/medical-devices/blood-glucose-monitoring-devices/faqs-home-use-blood-glucose-meters-utilized-within-hospitals-during-covid-19-pandemic
3 Replies
Reply
Subgroup Membership is required to post Replies
Join POCT Listserv now
Suggested Posts
| Topic | Replies | Likes | Views | Participants | Last Reply |
|---|---|---|---|---|---|
| LABORATORY QUALITY SEASONAL SCHOOL 2025 | 0 | 1 | 108 | ||
| Southwest Regional Point of Care Conference, Nov 7-8, 2024 ~ Welcome to Phoenix!! | 0 | 0 | 231 | ||
| NW POCT Conference- October 3-4 2024 | 1 | 1 | 328 |
Unless we have to use telehealth for the visit, all patients continue to get blood glucose by fingerstick using our hospital system glucose meter, by employees.
We are doing the same as Peggy mentioned. No changes so using our hospital meters.
No changes here either.
My first thought would be the high likelihood that staff would be tempted to enter in the glucometer results from their personal glucometer into the patients electronic medical record if they can. This would lead you into a number of issues you don't want... potential billing of this test and incorrect documentation if it wasn't built into the LIS/HIS correctly = nope, I'm passing on this.
I've removed the floors ability to manually enter in glucometer results into the LIS for several reasons including this one.